Ambrosia Biosciences

Ambrosia Biosciences, Inc. is a privately held drug discovery company developing oral small-molecule therapies for obesity and other metabolic disorders. The company’s platform offers a non-invasive approach to weight management and metabolic health, enabling patients to effectively manage their conditions with fewer side effects compared to some traditional medications.